Marten Visser

Marten Visser is a Cell Therapy Specialist at NecstGen since October 2021, focusing on adoptive T cell therapy for melanoma and ovarian carcinoma patients, as well as cancer immunology and neoantigens. Prior to this role, Marten served as a Senior Research Technician at Oncode Institute from April 2019 to October 2021 and at Leiden University Medical Center from March 2008 to October 2021, gaining extensive experience in research and development in the field of cancer therapy. Marten holds a degree from Vrije Universiteit Amsterdam, completed between 1994 and 1999.